Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
G2 Intelligence is a premier provider of news, analysis, and regulatory information tailored for the diagnostic laboratory and pathology industries. The company offers a suite of specialized publications, webinars, and annual conferences designed to help laboratory professionals manage business, legal, and compliance risks. Its coverage includes critical updates on CMS regulations, FDA oversight, and reimbursement shifts under the Protecting Access to Medicare Act (PAMA). Since its acquisition by LabX Media Group in 2021, G2 Intelligence continues to serve as a vital resource for laboratory executives, clinical managers, and pathologists navigating the evolving healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on G2 Intelligence.